Abstract
Background
Delta check is widely used for detecting specimen mix-ups. Owing to the inadequate specificity and sparseness of the absolute incidence of mix-ups, the positive predictive value (PPV) of delta check is considerably low as it is labor consuming to identify true mix-up errors among a large number of false alerts. To overcome this problem, we developed a new accurate detection model through machine learning.
Methods
Inspired by delta check, we decided to conduct comparisons with the past examinations and broaden the time range. Fifteen common items were selected from complete blood cell counts and biochemical tests. We considered examinations in which ≥11 among the 15 items were measured simultaneously in our hospital; we created individual partial time-series data of the consecutive examinations with a sliding window size of 4. The last examinations of the partial time-series data were shuffled to generate artificial mix-up cases. After splitting the dataset into development and validation sets, we allowed a gradient-boosting-decision-tree (GBDT) model to learn using the development set to detect whether the last examination results of the partial time-series data were artificial mixed-up results. The model’s performance was evaluated on the validation set.
Results
The area under the receiver operating characteristic curve (ROC AUC) of our model was 0.9983 (bootstrap confidence interval [bsCI]: 0.9983–0.9985).
Conclusions
The GBDT model was more effective in detecting specimen mix-up. The improved accuracy will enable more facilities to perform more efficient and centralized mix-up detection, leading to improved patient safety.
Acknowledgments
We would like to thank Editage (www.editage.jp) for English language proofreading.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Lippi G, Chance JJ, Church S, Dazzi P, Fontana R, Giavarina D, et al. Preanalytical quality improvement: from dream to reality. Clin Chem Lab Med 2011;49:1113–26.10.1515/CCLM.2011.600Search in Google Scholar PubMed
2. Lippi G, Blanckaert N, Bonini P, Green S, Kitchen S, Palicka V, et al. Causes, consequences, detection, and prevention of identification errors in laboratory diagnostics. Clin Chem Lab Med 2009;47:143–53.10.1515/CCLM.2009.045Search in Google Scholar PubMed
3. Simundic A-M, Church S, Cornes MP, Grankvist K, Lippi G, Nybo M, et al. Compliance of blood sampling procedures with the CLSI H3-A6 guidelines: an observational study by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) working group for the preanalytical phase (WG-PRE). Clin Chem Lab Med 2015;53:1321–31.10.1515/cclm-2014-1053Search in Google Scholar PubMed
4. Yamashita T, Ichihara K, Miyamoto A. A novel weighted cumulative delta-check method for highly sensitive detection of specimen mix-up in the clinical laboratory. Clin Chem Lab Med 2013;51:781–9.10.1515/cclm-2012-0752Search in Google Scholar PubMed
5. Randell EW, Yenice S. Delta checks in the clinical laboratory. Crit Rev Clin Lab Sci 2019;11:1–23.10.1080/10408363.2018.1540536Search in Google Scholar PubMed
6. Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, et al. Scikit-learn: machine learning in Python. J Mach Learn Res 2011;12:2825–30.Search in Google Scholar
7. Chen T, Guestrin C. XGBoost: a scalable tree boosting system. Proceedings of the 22nd ACM SIGKDD International Confereence on Knowledge Discovery Data Min – KDD 16. 2016;785–94.10.1145/2939672.2939785Search in Google Scholar
8. Health Level Seven International. FHIR [Internet]. [cited 2019 Jul 1]. http://hl7.org/fhir.Search in Google Scholar
9. Lundberg MitaniSM, Erion GG, Lee S-I. Consistent individualized feature attribution for tree ensembles. http://arxiv.org/abs/1802.03888. Accessed: 30 May 2019.Search in Google Scholar
©2020 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Editorial
- Progress in understanding the use of human chorionic gonadotropin as a tumor marker
- Reviews
- Biomarkers for prostate cancer: prostate-specific antigen and beyond
- Gut microbiome investigation in celiac disease: from methods to its pathogenetic role
- Opinion Papers
- Understanding and managing interferences in clinical laboratory assays: the role of laboratory professionals
- A step forward in identifying the right human chorionic gonadotropin assay for testicular cancer
- EFLM Opinion Paper
- Validation and verification of examination procedures in medical laboratories: opinion of the EFLM Working Group Accreditation and ISO/CEN standards (WG-A/ISO) on dealing with ISO 15189:2012 demands for method verification and validation
- Guidelines and Recommendations
- An updated protocol based on CLSI document C37 for preparation of off-the-clot serum from individual units for use alone or to prepare commutable pooled serum reference materials
- General Clinical Chemistry and Laboratory Medicine
- Highly accurate and explainable detection of specimen mix-up using a machine learning model
- Impact of delta check time intervals on error detection capability
- Effect of long-term frozen storage and thawing of stool samples on faecal haemoglobin concentration and diagnostic performance of faecal immunochemical tests
- A more accurate prediction to rule in and rule out pre-eclampsia using the sFlt-1/PlGF ratio and NT-proBNP as biomarkers
- Macro vitamin B12: an underestimated threat
- Evaluation of the primary biliary cholangitis-related serologic profile in a large cohort of Belgian systemic sclerosis patients
- High frequency of anti-parietal cell antibody (APCA) and intrinsic factor blocking antibody (IFBA) in individuals with severe vitamin B12 deficiency – an observational study in primary care patients
- DOAC-Remove abolishes the effect of direct oral anticoagulants on activated protein C resistance testing in real-life venous thromboembolism patients
- Cancer Diagnostics
- How comparable are total human chorionic gonadotropin (hCGt) tumour markers assays?
- Diabetes
- Measurement accuracy of two professional-use systems for point-of-care testing of blood glucose
- Letters to the Editor
- Human chorionic gonadotropin in oncology: a matter of tight (bio)marking
- More robust analytical evidence should support the selection of human chorionic gonadotropin assays for oncology application
- Letter in reply to the letter to the editor of Ferraro S and Panteghini M with the title “More robust analytical evidence should support the selection for human chorionic gonadotropin assays for oncology application”
- Definition of analytical quality specifications for serum total folate measurements using a simulation outcome-based model
- Alarmed by misleading interference in free T3 and free T4 assays: a new case of anti-streptavidin antibodies
- A root cause analysis of ‘falsely elevated’ oxygen saturation: investigation of pneumatic tube transport and differences between estimated and measured saturation in a critical patient population
- The chaos of serologic markers in interstitial pneumonia with autoimmune features can be corrected by the laboratory physician
- Vitamin A and E gender and age stratification in adults
- Detection of monoclonal B-lymphocytosis: interest of cellular population data and CytoDiff™ analysis
- Urinary reference intervals for gadolinium in individuals without recent exposure to gadolinium-based contrast agents
- Molecular diagnosis of toxoplasmosis: evaluation of automated DNA extraction using eMAG® (bioMérieux) on buffy coat, cerebrospinal and bronchoalveolar lavage fluids
- Retraction
- Retraction of: The Effect of a Gender Difference in the Apolipoprotein E Gene DNA Polymorphism on Serum Lipid Levels in a Serbian Healthy Population
Articles in the same Issue
- Frontmatter
- Editorial
- Progress in understanding the use of human chorionic gonadotropin as a tumor marker
- Reviews
- Biomarkers for prostate cancer: prostate-specific antigen and beyond
- Gut microbiome investigation in celiac disease: from methods to its pathogenetic role
- Opinion Papers
- Understanding and managing interferences in clinical laboratory assays: the role of laboratory professionals
- A step forward in identifying the right human chorionic gonadotropin assay for testicular cancer
- EFLM Opinion Paper
- Validation and verification of examination procedures in medical laboratories: opinion of the EFLM Working Group Accreditation and ISO/CEN standards (WG-A/ISO) on dealing with ISO 15189:2012 demands for method verification and validation
- Guidelines and Recommendations
- An updated protocol based on CLSI document C37 for preparation of off-the-clot serum from individual units for use alone or to prepare commutable pooled serum reference materials
- General Clinical Chemistry and Laboratory Medicine
- Highly accurate and explainable detection of specimen mix-up using a machine learning model
- Impact of delta check time intervals on error detection capability
- Effect of long-term frozen storage and thawing of stool samples on faecal haemoglobin concentration and diagnostic performance of faecal immunochemical tests
- A more accurate prediction to rule in and rule out pre-eclampsia using the sFlt-1/PlGF ratio and NT-proBNP as biomarkers
- Macro vitamin B12: an underestimated threat
- Evaluation of the primary biliary cholangitis-related serologic profile in a large cohort of Belgian systemic sclerosis patients
- High frequency of anti-parietal cell antibody (APCA) and intrinsic factor blocking antibody (IFBA) in individuals with severe vitamin B12 deficiency – an observational study in primary care patients
- DOAC-Remove abolishes the effect of direct oral anticoagulants on activated protein C resistance testing in real-life venous thromboembolism patients
- Cancer Diagnostics
- How comparable are total human chorionic gonadotropin (hCGt) tumour markers assays?
- Diabetes
- Measurement accuracy of two professional-use systems for point-of-care testing of blood glucose
- Letters to the Editor
- Human chorionic gonadotropin in oncology: a matter of tight (bio)marking
- More robust analytical evidence should support the selection of human chorionic gonadotropin assays for oncology application
- Letter in reply to the letter to the editor of Ferraro S and Panteghini M with the title “More robust analytical evidence should support the selection for human chorionic gonadotropin assays for oncology application”
- Definition of analytical quality specifications for serum total folate measurements using a simulation outcome-based model
- Alarmed by misleading interference in free T3 and free T4 assays: a new case of anti-streptavidin antibodies
- A root cause analysis of ‘falsely elevated’ oxygen saturation: investigation of pneumatic tube transport and differences between estimated and measured saturation in a critical patient population
- The chaos of serologic markers in interstitial pneumonia with autoimmune features can be corrected by the laboratory physician
- Vitamin A and E gender and age stratification in adults
- Detection of monoclonal B-lymphocytosis: interest of cellular population data and CytoDiff™ analysis
- Urinary reference intervals for gadolinium in individuals without recent exposure to gadolinium-based contrast agents
- Molecular diagnosis of toxoplasmosis: evaluation of automated DNA extraction using eMAG® (bioMérieux) on buffy coat, cerebrospinal and bronchoalveolar lavage fluids
- Retraction
- Retraction of: The Effect of a Gender Difference in the Apolipoprotein E Gene DNA Polymorphism on Serum Lipid Levels in a Serbian Healthy Population